Abstract
BioID was performed using FlagBirA⁎ (the R118G biotin ligase mutant protein) and FlagBirA⁎-Myc in HEK293 T-REx cells maintained both under standard cell culture conditions and as mouse xenografts. The mass spectrometry dataset acquired in this study has been uploaded to the MassIVE repository with ID: MSV000078518, and consists of 28 ⁎.raw MS files acquired on an Orbitrap Velos instrument, collected in data-dependent mode. iProphet processed MS/MS search results are also included as a reference. This study has been published as “BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors”, by Dingar et al. in the Journal of Proteomics, 2014 [1].
Highlights
Princess Margaret Cancer Centre, University Health Network, and Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada article info
The mass spectrometry dataset acquired in this study has been uploaded to the MassIVE repository with ID: MSV000078518, and consists of 28 n.raw MS files acquired on an Orbitrap Velos instrument, collected in data-dependent mode. iProphet processed MS/MS search results are included as a reference
Biology Proteomics, Protein–protein interactions Mass spectrometry RAW files Mass Spectrometry (Thermo Orbitrap Velos) RAW unprocessed files Bait protein maintained under standard culture conditions and as xenografts BioID using the human c-MYC protein as bait MassIVE Available on MassIVE, ID: MSV000078518
Summary
BioID data of c-MYC interacting protein partners in cultured cells and xenograft tumors. BioID was performed using FlagBirAn (the R118G biotin ligase mutant protein) and FlagBirAn-Myc in HEK293 T-REx cells maintained both under standard cell culture conditions and as mouse xenografts. This study has been published as “BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors”, by Dingar et al in the Journal of Proteomics, 2014 [1].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.